Perma-Fix Medical Investor Presentation January 2016

Perma-Fix Medical presents disruptive technology for producing Technetium-99m, a commonly used medical isotope, with lower costs and reduced radioactive waste. The company addresses a multi-billion dollar market facing significant supply chain challenges, with FDA submission planned for 2016 and validated technology partnerships supporting commercialization.